Keywords: ACEi; angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; BMI; body mass index; CKD; chronic kidney disease; DBP; diastolic blood pressure; eGFR; estimated glomerular filtration rate; ESRD; end-stage renal disease; FPE; foot proces